Psilocybin shows promising potential for reducing cluster headache frequency and severity, offering relief for individuals who struggle to find effective treatments. Early results are encouraging, but more research is needed to determine long term effectiveness and standardized treatment protocols.
Psilocybin may meaningfully reduce migraine frequency. Benefits appear to occur even without strong psychedelic effects, which opens the door for future low dose or targeted treatments. More research is needed to understand optimal dosing and long term outcomes.
Research
